Kurt Puentener

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 8 CIPO patents and 15 EPO patents, primarily in Oligonucleotide Chemistry. Top assignees: Hoffmann-La Roche Inc., Roche Colorado Corporation, Roche Palo Alto LLC. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt Puentener. Retrieved from https://idiyas.com/inventor/kurt-puentener

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 12)

% Patents Active = 58.3

CIPO Patents = 8 (Patent Applications = 13)

EPO Patents = 15 (Patent Applications = 23)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 36(Granted Patents)

Company Filing History:

14 out of 5,026

Hoffmann-La Roche Inc.

patents

5 out of 18

Roche Colorado Corporation

F. Hoffmann-La Roche Ag

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Oligonucleotide Products

Chiral Propionic Acids

Metathesis Catalysts

Imidazo[1,5-a]Pyrazines

Lysine-Glutamic Acid

Ruthenium Complexes

Phosphine Ligands

GalNAc Conjugates

Pyrazole Amides

Macrocycle Preparation

Dipeptide Derivatives

Epothilone Derivatives

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12654144 - Process for the preparation of spray dried oligonucleotide products with controlled humidity (2026-06-16),

2. 12637702 - PROCESS FOR PREPARING SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES (2026-05-26),

3. 12139506 - Process for the preparation of GalNAc phosphoramidite epimers (2024-11-12),

4. 11021503 - Process for GalNAc oligonucleotide conjugates (2021-06-01),

5. 9802886 - Process for making lysine-glutamic acid dipeptide derivatives (2017-10-31),

6. 9522874 - Lysine-glutamic acid dipeptide derivatives (2016-12-20),

7. 9505759 - Pd-catalyzed coupling of pyrazole amides (2016-11-29),

8. 9115130 - Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives (2015-08-25),

9. 8450496 - Process for the preparation of propionic acid derivatives (2013-05-28),

10. 8344161 - Process for the preparation of pyrollidine-3-carboxylic acids (2013-01-01),

11. 8288534 - Process for the preparation a ruthenium complex (2012-10-16),

12. 7939668 - Ruthenium complexes as catalysts for metathesis reactions (2011-05-10),

13. 7910728 - Process for the preparation of a macrocycle (2011-03-22),

14. 7781586 - Metathesis catalysts (2010-08-24),

15. 7642366 - Phosphine ligands (2010-01-05),

Title: The Innovative Mind of Kurt Puentener

Introduction: Kurt Puentener is a visionary inventor based in Basel, Switzerland, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kurt Puentener holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence, and medical devices.

Career Highlights: With a career spanning over two decades, Kurt Puentener has been at the forefront of technological innovation, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Kurt Puentener has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Kurt Puentener's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a pioneering inventor in the global innovation landscape.

Profile summary based on public USPTO records.